Found: 35
Select item for more details and to access through your institution.
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification.
- Published in:
- European Radiology, 2021, v. 31, n. 8, p. 5913, doi. 10.1007/s00330-020-07664-1
- By:
- Publication type:
- Article
Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
- Published in:
- European Radiology, 2013, v. 23, n. 9, p. 2420, doi. 10.1007/s00330-013-2850-x
- By:
- Publication type:
- Article
Intraoperative Radiotherapy for Breast Cancer in Elderly Women.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5
- By:
- Publication type:
- Article
TP53 Status and Response to Chemotherapy in Breast Cancer.
- Published in:
- Pathobiology, 2008, v. 75, n. 2, p. 132, doi. 10.1159/000123851
- By:
- Publication type:
- Article
Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.
- Published in:
- Journal of Pathology, 2001, v. 194, n. 4, p. 413, doi. 10.1002/path.902
- By:
- Publication type:
- Article
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 71, n. 6, p. 921, doi. 10.1111/j.1365-2125.2010.03896.x
- By:
- Publication type:
- Article
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1331, doi. 10.3390/cancers14051331
- By:
- Publication type:
- Article
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2657, doi. 10.3390/cancers12092657
- By:
- Publication type:
- Article
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 429, doi. 10.1007/s10549-010-0939-3
- By:
- Publication type:
- Article
Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 11, p. 2732, doi. 10.1002/cam4.1201
- By:
- Publication type:
- Article
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 3, p. 1, doi. 10.1186/bcr3421
- By:
- Publication type:
- Article
Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 9, p. 1225, doi. 10.1007/s11864-024-01252-x
- By:
- Publication type:
- Article
Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 9, p. 1210, doi. 10.1007/s11864-024-01251-y
- By:
- Publication type:
- Article
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 7, p. 1145, doi. 10.1007/s00259-017-3641-4
- By:
- Publication type:
- Article
F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 983, doi. 10.1007/s00259-015-3295-z
- By:
- Publication type:
- Article
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1682, doi. 10.1007/s00259-015-3110-x
- By:
- Publication type:
- Article
Early monitoring of response to neoadjuvant chemotherapy in breast cancer with F-FDG PET/CT: defining a clinical aim.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Correlation of high F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 3, p. 426, doi. 10.1007/s00259-010-1640-9
- By:
- Publication type:
- Article
Should FDG PET/CT be used for the initial staging of breast cancer?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1539, doi. 10.1007/s00259-009-1159-0
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 4, p. 536, doi. 10.2967/jnumed.115.163907
- By:
- Publication type:
- Article
Baseline Tumor <sup>18</sup>F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 6, p. 824, doi. 10.2967/jnumed.115.154138
- By:
- Publication type:
- Article
Comparison Between <sup>18</sup>F-FDG PET Image--Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 341, doi. 10.2967/jnumed.112.108837
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 5, doi. 10.2967/jnumed.112.106864
- By:
- Publication type:
- Article
Triple-Negative Breast Cancer: Early Assessment with <sup>18</sup>F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 249, doi. 10.2967/jnumed.111.094045
- By:
- Publication type:
- Article
The Yield of <sup>18</sup>F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1526, doi. 10.2967/jnumed.111.093864
- By:
- Publication type:
- Article
The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 405, doi. 10.2967/jnumed.110.081711
- By:
- Publication type:
- Article
Distinct tumor protein p53 mutants in breast cancer subgroups.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 5, p. 1227, doi. 10.1002/ijc.27767
- By:
- Publication type:
- Article
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 11, p. 1960, doi. 10.1002/cncr.28020
- By:
- Publication type:
- Article
Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer.
- Published in:
- Oncology, 2001, v. 60, n. 4, p. 303, doi. 10.1159/000058524
- By:
- Publication type:
- Article
Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers.
- Published in:
- Oncologist, 2010, v. 15, n. 3, p. 246, doi. 10.1634/theoncologist.2009-0243
- By:
- Publication type:
- Article
Prognostic Impact of <sup>18</sup>FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 24, p. 1879, doi. 10.1093/jnci/djs451
- By:
- Publication type:
- Article